|
|
News Breaks | | | | November 8, 2012 | | 07:57 EDT |  | CRTX | Cornerstone Therapeutics on track to achieve in excess of $8M in EKR synergies
CEO Craig A. Collard commented: "The integration of EKR Therapeutics was completed successfully and rapidly, well ahead of our plans, and we are on track to achieve in excess of $8 million in synergies during 2H of 2012. We plan to use our positive momentum to seek out additional acquisition opportunities to fuel our growth." | |
|
News For CRTX From The Last 14 Days Check below for free stories on CRTX the last two weeks. |
|
|
| There are no results for CRTX |
|
|
|
|
|
|
